Differentiated Thyroid Gland Carcinoma
1 competing product in clinical development for Differentiated Thyroid Gland Carcinoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib | Eisai | Phase 2 | Terminated | 27 |
1 competing product in clinical development for Differentiated Thyroid Gland Carcinoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lenvatinib | Eisai | Phase 2 | Terminated | 27 |